bupivacaine has been researched along with Cytomegalovirus in 1 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Cytomegalovirus: A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endrész, V | 1 |
| Burián, K | 1 |
| Berencsi, K | 1 |
| Gyulai, Z | 1 |
| Kari, L | 1 |
| Horton, H | 1 |
| Virok, D | 1 |
| Méric, C | 1 |
| Plotkin, SA | 1 |
| Gönczöl, E | 1 |
1 other study available for bupivacaine and Cytomegalovirus
| Article | Year |
|---|---|
Optimization of DNA immunization against human cytomegalovirus.
Topics: Animals; Antibodies, Viral; Antigens, Viral; Bupivacaine; Cytomegalovirus; Cytomegalovirus Infection | 2001 |